Skip to main content

Coronavirus

By Philipp Grätzel von Grätz | 07:36 am | June 24, 2020
Infection surveillance and infection control are part of what makes countries successful that manage to keep the SarsCoV2 pandemic in check. Properly implemented, digital solutions can help a lot with testing, tracing and isolating. Striking the right balance between meeting public health requirements and upholding privacy is not easy though. 
By Sara Mageit | 05:23 am | June 24, 2020
Pagabo and Moodbeam have collaborated to aid mental health and wellbeing and improve working conditions in the construction sector.
By HIMSS Media | 06:02 pm | June 19, 2020
HIMSS Media sits down with another VR researcher to discuss virtual medicine and VR's multidisciplinary potential for care.
By Ahmed El Sherif | 10:00 am | June 19, 2020
In a new investigation by Amnesty International, the two Gulf states and Norway have released apps that reportedly operate as mass surveillance tools.
By Piers Ford | 09:25 am | June 19, 2020
Demand for tech solutions has soared in Finland during the pandemic as healthcare providers seek new ways to diagnose and treat patients, and source properly tested PPE.
By Sara Mageit | 05:06 am | June 19, 2020
Also, Medwise.ai wins UK grant to develop AI-powered question answering platform for healthcare professionals during COVID-19.
By Dave Muoio | 12:59 pm | June 17, 2020
Quarantined basketball players will have the option to wear the smart rings for health tracking, and a "proximity alarm" that sounds when another wearer is too close for too long.
By MobiHealthNews | 04:57 pm | June 12, 2020
VR researcher and advocate Dr. Robert Louis gives HIMSS Media insight on the current state of VR in healthcare, and how the virus has impacted his hospital's rollout of the technology.  
By Sophie Porter | 02:40 am | June 12, 2020
The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed.
By Rachel McArthur | 08:07 am | June 10, 2020
Group 42 and Oxford Nanopore Technologies have released details of a promising end-to-end solution that can mass screen for SARS-CoV-2.